Adjunct Instructor in Economics, Finance, Social Media Marketing, Tribal Leadership, Tribal Entrepreneurship, Resource and Economic Development at SIPI, a national Tribal College with focus on students from tribes of the southwestern and plains states. Past Director, Board of Regents Office; PI of a NASA grant awarded to SIPI - 2014-18. Co-PD of a research study into the efficacy of the cooperative model as a means for US tribes and Canadian First Nations to both improve their economic conditions and preserve their native cultures 2019-2026. Primary focus is economic development of America's tribes, on their own terms, so as to support the maintenance and development of their cultures, traditions and communities.

Ceo2ceos is a Forum for CEOs and top executives to share experience and insights to help their peers more effectively address business opportunities and challenges.

Taught Finance for Entrepreneurs and Leadership for Entrepreneurs to budding and established entrepreneurs either in the San Francisco Bay Area or who had offices in the Bay Area.

Owned and operated Silicon Valley franchise of Renaissance Executive Forums. Built and facilitated as many as 4 peer-review advisory boards for top executives and their key executives. Average increase in revenue growth in first year with the Forum was over 55%, and average increase in profitability growth was over 500%. $200K Club recipient three times,

Division responsibility for establishing strategic marketing direction, designing and implementing marketing campaigns, evaluating new market and product opportunities. Directed marketing functions for $2-billion plus specialty pharmaceutical distributor. Increased volume share of Taxol, a leading cancer drug, in from 45% to 65% of paclitaxel market in office-based oncology by launching and managing a customer segmentation program. Maintained 10% to 20% average price premium over generics and significantly surpassed revenue projections in both 2002 and 2003. Nominated for 2003 BMS President’s Award for Taxol Program.

Corporate responsibility for evaluating new market and product opportunities, in and out-licensing of products, and negotiating distribution agreements. Developed sales force planning, and planning and execution of product introductions for a development-stage pharmaceutical company. Increased European sales potential for lead product by over 25% by negotiating southern European distribution agreement. Increased profit potential for product over previous contracts by improving royalties and transfer pricing.

Most significantly, coordinated an industry effort, supported by key individuals in the surgical community, to fend off an FDA threat to curtail marketing of our largest selling product

Directed U.S. marketing, sales and distribution for Hemostatix Corporation, a holding of the Shaw Group. Directed product development and market evaluation efforts for new surgical and diagnostic technologies for an under $10-million medical device and product incubation company. Increased sales by 30% by introducing second generation heated scalpel technology, and positioned company for significant five-year growth. Developed market for new bipolar scissors and forceps for endoscopic surgery and bipolar scissors for open surgery.

Developed international distributors, focusing principally on Europe, and managed these distributors. Increased international sales by more than 720% and domestic sales by over 100% by identifying, contracting and managing marketing partners in the US, Europe, Asia/Pacific, and the Middle East/Africa

Transitioned the surgical stapling program from Baxter to 3M following 3M's purchase of the business. Coordinated business transition with 3M managers to integrate the surgical stapling business into 3M. Provided marketing input and market introduction planning for five new product teams with combined fifth year sales potential of $14 million. Directed marketing/sales support for sixteen 3M international subsidiaries selling surgical staples. International sales grew 185% in 1989

Managed both marketing and product development for surgical staplers and wound drainage. Developed and coordinated surgeon advisory boards to assist in future product development. Increased sales of surgical stapling line 385% and market share from 2.6% to 10% from 1983 to 1986